Novartis AG ADR

NYSE: NVS
$115.94
-$0.04 (0.0%)
Closing Price on September 20, 2024

NVS Articles

Reuters:   Bernanke may admit the economy is weak but not five details of the Fed’s plans. Reuters:   Hewlett-Packard (NYSE: HPQ) outbid Dell (NASDAQ: DELL) for 3Par (NYSE: PAR) by offering $27...
The number of analyst calls ahead of the three-day weekend are fairly small, as you would expect.  Some of this Friday’s top analyst research calls with upgrades, downgrades, and initiations seen...
Reuters:   The Senate was not able to reach consensus on the financial reform bill. Reuters:   Heavy oil from the BP plc (NYSE: BP) rig came ashore in Louisiana. Reuters:   Trading systems...
MarketWatch: Asia shares were off by 2%. Reuters:   Riots against austerity measures continued n Greece. Reuters:   US regulators want to increase supervision of broadband. Reuters:   The...
Reuters:   Google Inc.’s (NASDAQ: GOOG) password operation was hit by cyberattacks. Reuters:   A leading political party in Germany is urging that the nation not deal with Goldman Sachs Group...
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total  annual sales  of over $500 billion. The firms have...
The IPO market is off to a rough start so far in 2010.  We have seen very recent developments in deals on deck to price from CBOE Holdings Inc., Convio Inc., Everyday Health Inc.,...
Reuters:   Novartis (NYSE:NVS) will buy the part of Alcon (NYSE:ACL) that it does not currently own for $39 billion. Reuters:   JAL may receive a bailout from the Japanese government....
Markets in Asia were narrowly mixed. The Nikkei rose 1.1% to 10,865. JAL rose on news of government financial support. The Hang Seng fell .2% to 21,823. The Shanghai Composite dropped 1% to 3,244. At...
Reuters:   Ken Lewis will step down as CEO of Bank of America (BAC) Reuters:   Cisco (CSCO) bought Tandbeg  for $3 billion. Reuters:   The IMF raised forecasts for US GDP but warned on its...
These are this Tuesday morning’s top analyst upgrades and positive research calls that we have seen from Wall Street research with about two hours until the market opens: ArcelorMittal (MT) Raised...
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
There were many analyst calls this morning, but the problem is that most were on smaller companies or were by second and third tier boutiques.  These were the top call from Wall Street this Friday...
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
These are some of the top stocks for day traders and active traders to watch based on pre-market and after-hours volume activity with links to more detailed price and volume analysis on each...